Viral Vector And Plasmid DNA Testing Services Market, By Service Type, By End User, and By Region

Description

Viral Vector And Plasmid Dna Testing Services Market is estimated to be valued at USD 466.7 Mn in 2026 and is expected to reach USD 2,353.1 Mn by 2033, growing at a compound annual growth rate (CAGR) of 26.0% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 466.7 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	26.00%	2033 Value Projection:	USD 2,353.1 Mn

Testing services are crucial for the timely development of viral vector-based medicines since viral vectors are the best strategy for gene therapies. Characterization of the viral vector plays an essential role for orthogonal analytical methods. Through the regulatory prospective which includes product safety, identification, purity, and potency, the characterization is significant. These days, viral vectors are the primary delivery system for a variety of virus-based medications that have been created for various therapies for conditions including cancer, neurology, hematology, ophthalmology, metabolic or muscular disorders and are accepted on the global market. The pharmaceutical industry has a bright future for several developments based on viral-based medicines.

Market Dynamics

The ongoing clinical trials on the viral vectors and plasmid DNA for various treatment is expected to fuel growth of the market in the forecast period. For instance, in October, 2022, ICON plc, a clinical research organization, in collaboration with researchers from Imam Abdulrahman Bin Faisal University, based in Saudi Arabia, announced the initiation of Phase-I clinical trial Study to Evaluate the Safety and Immunogenicity of 2 or 3 dose regimen of investigational Prophylactic pDNA Vaccine Candidate Against COVID-19 in Healthy Adults. The pDNA vaccine candidate is administered intramuscularly (IM) by immunizing healthy adults (18-55 years).

Similarly, in January 2022, GeneOne Life Science, Inc., a biotechnology company, in collaboration with Inovio Pharmaceuticals, a biotechnology company, announced initiation of clinical trial to assess the safety, tolerability, and immunogenicity of GLS-5700. GLS-5700 is a synthetic DNA plasmid vaccine against the Zika virus, which is currently in Phase -1.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global viral vector and plasmid DNA testing services market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study are Charles River Laboratories, Inc., WuXi AppTec Co., Ltd., Cobra Biologics and Pharmaceutical Services, Merck KgaA, Lonza, Eurofins Scientific, FinVector Vision Therapies, Advanced Bioscience Laboratories, Inc., Takara Bio Inc., ViruSure GmbH, Genezen Laboratories, Akron Biotech., Catalent, Inc, AcuraBio., CATUG Biotechnology., Creative Biogene and Aldevron
Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global viral vector and plasmid DNA testing services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global viral vector and plasmid DNA testing services market

Detailed Segmentation:

Global Viral Vector and Plasmid DNA Testing Services Market, By Service Type (Revenue, USD Mn, 2021 - 2033)
Safety
Genetic Characterization
Purity
Identity
Potency
Global Viral Vector and Plasmid DNA Testing Services Market By End User:
Pharmaceutical and Biotechnology Industries
Research Organizations
Global Viral Vector and Plasmid DNA Testing Services Market, By Region (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa
Company Profiles
Charles River Laboratories, Inc.
WuXi AppTec Co., Ltd.
Cobra Biologics and Pharmaceutical Services
Merck KgaA
Lonza
Eurofins Scientific
FinVector Vision Therapies
Advanced Bioscience Laboratories, Inc.
Takara Bio Inc.
ViruSure GmbH
Genezen Laboratories
Akron Biotech.
Catalent, Inc
AcuraBio
CATUG Biotechnology.
Creative Biogene.
Aldevron

Product Code: CMI3637

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Service Type
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
- Merger, Acquisition, Collaborations
- Funding and Investment
- Future Prospective of Viral vector and plasma DNA testing
- Regulatory Guideline and Compliances
- Key Developments
- PEST Analysis
- PORTER's Analysis

4. Global Viral Vector and Plasmid DNA Testing Services Market, By Service Type, 2021-2033, (US$ Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Safety
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Genetic Characterization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Purity
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Identity
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Potency
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)

5. Global Viral Vector and Plasmid DNA Testing Services Market, By End User, 2021 - 2033, (US$ Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segments Trends
Pharmaceutical and Biotechnology Industries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)

6. Global Viral Vector and Plasmid DNA Testing Services Market, By Region, 2021 - 2033, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Million)
  - North Africa
  - Central Africa
  - South Africa

7. Competitive Landscape

Charles River Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
WuXi AppTec Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Cobra Biologics and Pharmaceutical Services
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Merck KgaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Lonza
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Eurofins Scientific
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
FinVector Vision Therapies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Advanced Bioscience Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Takara Bio Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
ViruSure GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Genezen Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Akron Biotech.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Catalent, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
AcuraBio.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
CATUG Biotechnology.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Creative Biogene.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Aldevron
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies

8. Section

Research Methodology
About Us